AAVnerGene Inc is an innovative company specialized in AAV technologies. It is founded by a group of AAV gene therapy enthusiasts who dream to serve the community, promote and lead the future of gene therapy. Our passion is to solve the bottleneck problems in AAV gene therapy and find more and better cures for all the patients. We believe that hard core technologies are the key to achieve it. With 20 years of frontline gene therapy experience, our team develops novel AAV vectors, methods and strategies that can efficiently produce, deliver and express high quality vectors into specific cells. Our goal is to increase AAV gene therapy efficacy and decrease the cost, making it accessible and affordable to patients. Our highly complex AAV capsid libraries allow us to efficiently select the best AAV capsid for each cell type in a high-throughput manner. Our abundant resources of AAV capsid serotypes, variants and efficient selection methods allow us to quickly identify the best AAV vector for each cell type and disease. Our AAV design, clone and production services provide consistent, high quality, affordable AAV vectors for our customers. Our AAV capsid and library selection services help our customer develop their own novel AAV capsids. Our novel AAV production technologies significantly decrease the AAV production cost.
